Specialty Pharmacy

Cancer therapy filgrastim-sndz (Zarxio) was initially approved on March 6, 2015.

Oncologists will now be able to measure progress in cancer treatments.

Addition of docetaxel had the greatest benefit in patients with a high burden of metastatic disease.

Pharmacists vital in helping HIV-infected women stay adherent to their treatment regimen.

Discovery holds promise for patients with Crohn's disease, diabetes, ulcerative colitis, and more.

RA drug found to improve physical and emotional well-being among patients.

Elotuzumab is an immunostimulatory antibody combination therapy for patients who received one or more prior therapies.

Genentech official sheds light on the current cancer drug pipeline.

HbA1C significantly decreased in adults with poorly controlled type 2 diabetes.

Findings may lead to safer cancer treatments without side effects harmful to the brain.

Entecavir treats chronic hepatitis B infection in adults with evidence of active viral replication.

Protein may hold key to eradicating cancer cells.

Afatinib treats patients with advanced squamous cell carcinoma of the lung that progressed after chemotherapy.

Paul Sipes, vice president of Spud Software, discusses how specialty pharmacies can benefit from the use of a data warehouse.

Long-term aspirin use may lessen colorectal cancer risk.

Link found between race and breast cancer life expectancy.

Dogs show promise in sniffing out melanoma, bladder, lung, breast, and ovarian cancers.

Access to high cost curative antiviral HCV drugs remains a challenge for patients.

Psoriasis treatment may improve more than just skin issues.

Research may lead to improve rheumatoid arthritis treatment.

Genetically reduced vitamin D levels could increase susceptibility to MS.

Drug shows promise treating chronic and potentially life-threatening skin disease.

Health care professionals advised to discontinue drug regimen when appropriate.

Nanotechnology may lead to breakthroughs in the treatment of several diseases.

The FDA has proposed adding a 4-letter suffix to the names of biosimilars to distinguish them from their biologic counterparts.

Multidose medication dispensing at discharge (MMDD) involves supplying products that have been partially used during hospitalization to ensure continuity of care.

The 340B Program "mega-guidance" just released by the Health Resources and Services Administration (HRSA) clarifies how patients can receive deeply discounted drugs.

A significant increase in breast cancer development was found among a specific subset of women.